Find clinical trials for Chronic Lymphocytic Leukemia in Birmingham, AL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Chronic Lymphocytic Leukemia trials near Birmingham, AL, USA:
Study is a phase I study to determine the maximum tolerated dose of adding Loncastuximab Tesirine to Aclabrutinib in the treatment of chronic...
Phase 1
Birmingham, Alabama, United States
Epcoritamab will be tested either inRelapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) as:* Monotherapy, or* Com...
Phase 1, Phase 2
Birmingham, Alabama, United States and 80 other locations
This is a Phase 1/2, open-label, multicenter study to determine the efficacy and safety of JCAR017 in adult subjects with relapsed or refractory CLL...
Phase 1, Phase 2
Birmingham, Alabama, United States and 83 other locations
with pirtobrutinib in patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) or small lymphocytic...
Phase 3
Birmingham, Alabama, United States and 217 other locations
This is a Phase I dose-finding study of FT819 as monotherapy and in combination with IL-2 in subjects with relapsed/refractory B-cell Lymphoma, Chronic...
Phase 1
Birmingham, Alabama, United States and 17 other locations
Study consists of two main parts to explore tacabrutideg recommended dosing, a Phase 1 monotherapy dose finding comprised of monotherapy dose escalat...
Phase 1, Phase 2
Birmingham, Alabama, United States and 117 other locations
The purpose of this clinical trial is to compare drug combinations to learn which drugs work best to prevent graft-versus-host-disease (GVHD) in peop...
Phase 2
Birmingham, Alabama, United States and 12 other locations
SLS009 (formerly GFH009) is a potent and highly selective CDK9 inhibitor. In this study the safety, tolerability, and antitumor activity of single ag...
Phase 1, Phase 2
Birmingham, Alabama, United States and 31 other locations
Clinical trials
Research sites
Resources
Legal